Company

Alibaba Health Reports 30.1% Revenue Growth in 2022 Financial Report

CompanyDrug

Enhertu, HER2-Targeted ADC, Officially Launched in China for Breast Cancer Treatment

CompanyDrug

BeiGene’s Tislelizumab Approved in China for First-Line Esophageal Squamous Cell Carcinoma

CompanyDrug

Bayer’s Copanlisib (Aliqopa) Approved by NMPA for Recurrent Follicular Lymphoma

CompanyDeals

Azenta Life Sciences and Vazyme Biotech Form Global Partnership for Comprehensive Services

CompanyDrug

3SBio Inc. Initiates Phase III Clinical Study for Thrombopoietin in Chronic Liver Disease Patients

CompanyDrug

Shanghai Junshi Biosciences’ Tuoyi Combo for Triple Negative Breast Cancer Accepted for Review

CompanyDrug

Oculis’ OCS-01 Achieves Primary Efficacy Endpoint in Phase III DIAMOND Trial for DME

CompanyDeals

Nona Biosciences and ModeX Therapeutics Partner to Develop Polyspecific Antibodies

Policy / Regulatory

NHSA Proposes Draft to Enhance Basic Medical Insurance Payment Management for Consumables

CompanyDrug

SinoMab BioScience’s SM17 IND Accepted by NMPA for Potential Global First-in-Class Monoclonal Antibody

Policy / Regulatory

China Aims to Establish Basic Elderly Care System by 2025, Outlines Comprehensive Plan